These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28822906)

  • 1. The impact of HTLV-1 on the cellular genome.
    Cook L; Melamed A; Yaguchi H; Bangham CR
    Curr Opin Virol; 2017 Oct; 26():125-131. PubMed ID: 28822906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis.
    Melamed A; Yaguchi H; Miura M; Witkover A; Fitzgerald TW; Birney E; Bangham CR
    Elife; 2018 Jun; 7():. PubMed ID: 29941091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
    Satou Y; Miyazato P; Ishihara K; Yaguchi H; Melamed A; Miura M; Fukuda A; Nosaka K; Watanabe T; Rowan AG; Nakao M; Bangham CR
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3054-9. PubMed ID: 26929370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
    Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
    Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
    Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
    J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
    Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
    Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.
    Fan J; Ma G; Nosaka K; Tanabe J; Satou Y; Koito A; Wain-Hobson S; Vartanian JP; Matsuoka M
    J Virol; 2010 Jul; 84(14):7278-87. PubMed ID: 20463074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
    Matsuoka M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.
    Matsuo M; Ueno T; Monde K; Sugata K; Tan BJY; Rahman A; Miyazato P; Uchiyama K; Islam S; Katsuya H; Nakajima S; Tokunaga M; Nosaka K; Hata H; Utsunomiya A; Fujisawa JI; Satou Y
    Nat Commun; 2022 May; 13(1):2405. PubMed ID: 35504920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
    Yasunaga J; Matsuoka M
    Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
    Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
    Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of human T-cell leukemia virus type 1 in genes of leukemia cells of patients with adult T-cell leukemia.
    Hanai S; Nitta T; Shoda M; Tanaka M; Iso N; Mizoguchi I; Yashiki S; Sonoda S; Hasegawa Y; Nagasawa T; Miwa M
    Cancer Sci; 2004 Apr; 95(4):306-10. PubMed ID: 15072587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL).
    Matsuoka M
    Retrovirology; 2005 Apr; 2():27. PubMed ID: 15854229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical indications of multiple integrations of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
    Shimamoto Y
    Leuk Lymphoma; 1997 Sep; 27(1-2):43-51. PubMed ID: 9373195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 intragenic viral enhancer influences immortalization phenotype
    Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
    Front Immunol; 2022; 13():954077. PubMed ID: 35958554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.
    Hashikura Y; Umeki K; Umekita K; Nomura H; Yamamoto I; Hasegawa H; Yanagihara K; Okayama A
    Hum Cell; 2016 Jul; 29(3):122-9. PubMed ID: 26940204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double integration band of HTLV-1 in a young patient with infective dermatitis who developed an acute form of adult T-cell leukemia/lymphoma.
    Oliveira PD; Magalhães M; Argolo JM; Bittencourt AL; Farre L
    J Clin Virol; 2013 Feb; 56(2):163-6. PubMed ID: 23182458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus.
    Miyazato P; Matsuo M; Katsuya H; Satou Y
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27322309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis.
    Ma G; Yasunaga J; Matsuoka M
    Retrovirology; 2016 Mar; 13():16. PubMed ID: 26979059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.